Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2012
10/04/2012US20120252726 Novel neurotrophic factors
10/04/2012US20120252717 Conjugates of biologically active proteins having a modified in vivo half-life
10/04/2012US20120252099 Immunogenic minicells and methods of use
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120252069 Process for the purification of glycoproteins
10/04/2012US20120252068 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
10/04/2012US20120252067 Systems for the Expression of Orthogonal Translation Components in Eubacterial Host Cells
10/04/2012US20120252066 Methods of foam control
10/04/2012US20120252065 Aqueous process for preparing protein isolate and hydrolyzed protein from an oilseed
10/04/2012US20120252064 Protease Enzyme and Uses Thereof
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251579 Compositions for generating an antigen specific immune response
10/04/2012US20120251554 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses
10/04/2012US20120251541 Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
10/04/2012US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/04/2012US20120251446 Peptide Conjugates Comprising Polyhistidine Sequence and Free Cysteine and Their Uses in Imaging
10/04/2012CA2831770A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012CA2830338A1 Antibody-drug conjugates
10/03/2012EP2505058A1 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
10/03/2012EP2504360A1 Monomeric antibody fc
10/03/2012EP2504355A1 Method for making polypeptides
10/03/2012CN1993463B Follistatin mutant polypeptide
10/03/2012CN1846000B HPV CD8+ T-cell epitopes
10/03/2012CN102712945A Methods and compositions for the treatment of proliferative and pathogenic diseases
10/03/2012CN102712923A Anti-iga1 antibody
10/03/2012CN102712921A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
10/03/2012CN102712696A Coiled coil and/or tether containing protein complexes and uses thereof
10/03/2012CN102712694A Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene
10/03/2012CN102711811A Antibody mimetic scaffolds
10/03/2012CN102711810A Antibody Fc mutants with ablated effector functions
10/03/2012CN102711809A Combination therapy of cancer with anti-endoglin antibodies and anti-VEGF agents
10/03/2012CN102711795A BChE albumin fusions for the treatment of cocaine abuse
10/03/2012CN102703555A Extraction and preparation method for micromolecule fishskin collagen peptide
10/03/2012CN102703554A Method for preparing oyster polypeptide from oyster shell
10/03/2012CN102703553A Method for using polysaccharide stem grafting coupling technique to improving pig plasma protein peptide antioxidant activity
10/03/2012CN102703552A Preparation method and products of recombinant human insulin
10/03/2012CN102703551A Novel method for adding decanoic acid in fermentation process of daptomycin
10/03/2012CN102703550A Method for extracting protein from high density fermentation broth of bacillus cereus
10/03/2012CN102703470A Compositions and methods for modulating pigment production in plants
10/03/2012CN102703468A Gene and polypeptide for regulating and controlling plant height of crop and application of polypeptide
10/03/2012CN102703457A Method for preparing and expressing antibacterial peptide gene
10/03/2012CN102703446A Compositions of trna and uses thereof
10/03/2012CN102703393A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
10/03/2012CN102702727A Preparation method for antibacterial composite material
10/03/2012CN102701507A Method for treating high-concentration wastewater of glutamic acid
10/03/2012CN102060922B Recombined human estrogen Alpha receptor ligand binding domain protein as well as preparation and application thereof
10/03/2012CN102021193B Method for producing polypeptide by combining biological expression of protein with chemical cracking technique
10/03/2012CN101568647B Secretion of antibodies without signal peptides from bacteria
10/03/2012CN101180313B Fermentation process for the production of diphtheria toxin
10/02/2012US8278498 Method for producing immortalised antibodies-secreting cells
10/02/2012US8278427 Molecule for assigning genotype to phenotype and components thereof as well as method for constructing assigning molecule and method for utilizing assigning molecule
10/02/2012US8278424 Antibodies that bind to PSCA proteins for diagnosis of cancer
10/02/2012US8278423 Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II)
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278421 Human antibodies specific for gastrin materials and methods
10/02/2012US8278270 HGF precursor protein variant and active protein thereof
10/02/2012US8278269 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
10/02/2012US8278085 RNA processing protein complexes and uses thereof
10/02/2012US8278068 Ex vivo human skin model
10/02/2012US8278065 Polynucleotides encoding anti-GD2 antibodies
10/02/2012US8278045 Methods for the detection, analysis and isolation of nascent proteins
10/02/2012US8278042 Compositions and methods for the diagnosis and treatment of tumor
10/02/2012US8278037 N-acetylgalactosamine transferases and nucleic acids encoding the same
10/02/2012US8277820 Process for preparing variant of Erysipelothrix rhusiopathiae surface protective antigen in E. coli
10/02/2012US8277804 Antagonists of IL-6 to prevent or treat thrombosis
10/02/2012US8277803 Cancerous disease modifying antibodies
10/02/2012CA2711007C G-csf analog compositions and methods
10/02/2012CA2492883C Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
10/02/2012CA2467215C Emulsion compositions
10/02/2012CA2430135C Recombinant anti-cd30 antibodies and uses thereof
10/02/2012CA2396534C Intrabodies with defined framework that is stable in a reducing environment and applications thereof
10/02/2012CA2345356C Transformation system in the field of filamentous fungal hosts
10/02/2012CA2223269C Hepatocyte growth factor receptor antagonists and uses thereof
10/02/2012CA2133306C Amplification of human mdm2 gene in human tumors
09/2012
09/27/2012WO2012129342A1 Compositions and methods for enhancing the pluripotency of stem cells
09/27/2012WO2012129036A2 Promoters for high level recombinant expression in fungal host cells
09/27/2012WO2012128661A1 Fusion protein, fusion protein-producing strain of escherichia coli bacteria and a method for producing methionine-free human interferon alpha-2b from said fusion protein
09/27/2012WO2012128143A1 Monoclonal antibody specific to west nile viral structural protein and method for determining west nile viral infection using monoclonal antibody
09/27/2012WO2012128082A1 Anti-mouse aggrus monoclonal antibody
09/27/2012WO2012126134A2 Recombinant cell that has a mutated cellular iron-transport mechanism and is transformed with a sequence that codes for a sulphur permease and with a sequence that codes for a high-affinity phosphate transporter, suitable for extracting phosphorus and/or sulphur from a solid or liquid medium that may have a high iron content
09/27/2012US20120245327 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated
09/27/2012US20120245103 Silk Proteins
09/27/2012US20120244636 Incorporation of methyl lysine into polypeptides
09/27/2012US20120244578 Monomeric antibody fc
09/27/2012US20120244577 Multivalent heteromultimer scaffold design and constructs
09/27/2012US20120244576 Compositions and methods for improved protein production
09/27/2012US20120244575 Cyclotide genes in the fabaceae plant family
09/27/2012US20120244176 Protein having immunogenicity of cedar pollen, polynucleotide encoding the protein, and use thereof
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012US20120244164 Biological materials related to c-met
09/27/2012US20120244163 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
09/27/2012US20120244162 Cross-species-specific bispecific binders
09/27/2012US20120244159 Specific Antibodies To Amyloid Beta Peptide, Pharmaceutical Compositions And Methods Of Use Thereof
09/27/2012US20120244154 Activatable Binding Polypeptides and Methods of Identification and Use Thereof
09/27/2012US20120244152 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
09/27/2012US20120244148 Anti-interferon-alpha antibodies
09/27/2012US20120244112 Mutant interleukin-2 polypeptides
09/27/2012US20120244076 csPCNA Isoform Antibodies And Uses Thereof
09/27/2012CA2836007A1 Mouse anti-aggrus monoclonal antibodies
09/26/2012EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 1125